Literature DB >> 3838797

Transient expression of human adenosine deaminase cDNAs: identification of a nonfunctional clone resulting from a single amino acid substitution.

S H Orkin, S C Goff, W N Kelley, P E Daddona.   

Abstract

Human adenosine deaminase (ADA) is an important purine catabolic enzyme which irreversibly deaminates adenosine and deoxyadenosine. Severe genetic deficiency of ADA leads to an immunological deficiency state in which T-lymphoid cells are selectively destroyed by the accumulation of toxic levels of deoxyadenosine and deoxy-ATP. In preparation for transfer of ADA sequences into a variety of cell types, we explored expression of ADA cDNAs transfected into cultured cells within a simian virus 40-based expression vector. After transfection into monkey kidney (COS) cells, ADA cDNA encompassing the entire coding region of the protein generated human ADA activity. An unexpected finding, however, was the identification of a cDNA clone that failed to produce either human enzyme activity or immunoreactive ADA protein. As this pattern is typical of many naturally occurring mutant ADA alleles, we characterized the molecular defect in this clone. DNA sequence analysis revealed a single nucleotide substitution in amino acid position 50 (glycine-valine). Northern blotting with a unique 17-mer oligonucleotide demonstrated the absence of the mutant sequence in the mRNA from which the cDNA library giving rise to the mutant cDNA was constructed. Therefore, the substitution in the variant cDNA was created during cloning. These data define one critical region of the human ADA protein molecule and suggest a convenient strategy for characterization of the phenotypes associated with naturally occurring mutant alleles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838797      PMCID: PMC366780          DOI: 10.1128/mcb.5.4.762-767.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Requirement for the 3' flanking region of the bovine growth hormone gene for accurate polyadenylylation.

Authors:  R P Woychik; R H Lyons; L Post; F M Rottman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

7.  Sequence of human adenosine deaminase cDNA including the coding region and a small intron.

Authors:  D A Wiginton; G S Adrian; J J Hutton
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

8.  Requirement of a downstream sequence for generation of a poly(A) addition site.

Authors:  M A McDevitt; M J Imperiale; H Ali; J R Nevins
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

9.  Human adenosine deaminase. cDNA and complete primary amino acid sequence.

Authors:  P E Daddona; D S Shewach; W N Kelley; P Argos; A F Markham; S H Orkin
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

10.  Cloning of cDNA sequences of human adenosine deaminase.

Authors:  D A Wiginton; G S Adrian; R L Friedman; D P Suttle; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more
  15 in total

1.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Identification and characterization of nine RFLPs at the adenosine deaminase (ADA) locus.

Authors:  S Tzall; A Ellenbogen; F Eng; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

3.  Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells.

Authors:  P J Mitchell; G Urlaub; L Chasin
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Aberrant expression of platelet-derived growth factor A-chain cDNAs due to cryptic splicing of RNA transcripts in COS-1 cells.

Authors:  R J Wise; S H Orkin; T Collins
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

5.  Identification of a point mutation resulting in a heat-labile adenosine deaminase (ADA) in two unrelated children with partial ADA deficiency.

Authors:  R Hirschhorn; S Tzall; A Ellenbogen; S H Orkin
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

6.  Identification of the base-pair substitution responsible for a human acid alpha glucosidase allele with lower "affinity" for glycogen (GAA 2) and transient gene expression in deficient cells.

Authors:  F Martiniuk; M Bodkin; S Tzall; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

7.  Escherichia coli aspartate transcarbamylase: a novel marker for studies of gene amplification and expression in mammalian cells.

Authors:  J C Ruiz; G M Wahl
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

8.  Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.

Authors:  T M Berkvens; E J Gerritsen; M Oldenburg; C Breukel; J T Wijnen; H van Ormondt; J M Vossen; A J van der Eb; P Meera Khan
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

9.  Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells.

Authors:  J M Wilson; O Danos; M Grossman; D H Raulet; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.

Authors:  D T Bonthron; A F Markham; D Ginsburg; S H Orkin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.